FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051133054> ?p ?o ?g. }

• W2051133054 endingPage "876" @default.
• W2051133054 startingPage "868" @default.
• W2051133054 abstract "Human immunodeficiency virus-1 (HIV-1) infection may produce neurological deficits, such as cognitive decline, that may be worsened by concurrent ethanol (EtOH) abuse. Among the many biochemical cascades likely mediating HIV-1-associated neuronal injury is enhancement of N-methyl-d-aspartate (NMDA) receptor function and progression to excitotoxicity, an effect that may be directly or indirectly related to accumulation in brain of the HIV-1 trans-activator of transcription (Tat) factor. The present studies were designed to examine the hypothesis that binge-like EtOH pre-exposure would enhance effects of Tat on NMDA receptor function. These studies employed a modified in vivo binge EtOH exposure regimen designed to produce peak blood EtOH levels (BEL) of <200 mg/dl in adult male rats and were designed to examine effects of intra-hippocampal injection of Tat (0.5 microl/500 pM/2 min) on EtOH withdrawal-related behavior, spatial learning, and histological measures. Unilateral cannulae were implanted into the cornu ammonis 1 (CA1) pyramidal cell layer of animals prior to beginning a 4-day binge EtOH regimen. EtOH was administered via intragastric intubation ( approximately 3.0-5.0 g/kg) with dose determined by behavioral ratings of intoxication daily for 4 days (at 08:00, 16:00, and 24:00 h). EtOH withdrawal behaviors were monitored 12 h after the last administration of EtOH. Morris water maze learning was assessed during the following 4 days, at which times brains were harvested for autoradiographic measurement of NMDA receptor density and neuroinflammation. Maximal BELs of 187.69 mg/dl were observed 60 min after EtOH administration on day 2 of the regimen. In contrast, peak BELs of approximately 100 mg/dl were observed 60 min after EtOH administration on day 4 of the regimen, suggesting development of metabolic tolerance. Significant behavioral abnormalities were observed in EtOH withdrawn animals, including tremor and seizures. Intra-CA1 region injection of Tat significantly potentiated EtOH withdrawal behavioral abnormalities, an effect that was reduced by MK-801 pre-exposure. While EtOH withdrawn animals showed learning similar to control animals, EtOH withdrawn animals that received intra-CA1 Tat injection demonstrated persisting deficits in spatial learning on days 3 and 4 of training, effects that were markedly reduced by administration of the competitive NMDA receptor antagonist MK-801 30 min prior to Tat injection. No changes in [(3)H]MK-801 binding were observed. Binding density of [(3)H]PK11195, a ligand for peripheral benzodiazepine receptors expressed on activated microglia, was elevated proximal to cannula tracks in all animals, but was not altered by EtOH or Tat exposure. These findings suggest that EtOH abuse and/or dependence in HIV-positive individuals may promote HIV-1-associated cognitive deficits by altering NMDA receptor function in the absence of microglial activation or neuroinflammation." @default.
• W2051133054 created "2016-06-24" @default.
• W2051133054 creator A5012733271 @default.
• W2051133054 creator A5021222735 @default.
• W2051133054 creator A5038633022 @default.
• W2051133054 creator A5052509069 @default.
• W2051133054 creator A5076025191 @default.
• W2051133054 date "2009-10-01" @default.
• W2051133054 modified "2023-10-05" @default.
• W2051133054 title "Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-d-aspartate glutamate receptors to produce persisting spatial learning deficits" @default.
• W2051133054 cites W1524845305 @default.
• W2051133054 cites W1570708643 @default.
• W2051133054 cites W1581091695 @default.
• W2051133054 cites W1921965910 @default.
• W2051133054 cites W1967659964 @default.
• W2051133054 cites W1968709066 @default.
• W2051133054 cites W1972738289 @default.
• W2051133054 cites W1974835419 @default.
• W2051133054 cites W1974898567 @default.
• W2051133054 cites W1977996289 @default.
• W2051133054 cites W1978013837 @default.
• W2051133054 cites W1979007089 @default.
• W2051133054 cites W1983807711 @default.
• W2051133054 cites W1985214340 @default.
• W2051133054 cites W1988867016 @default.
• W2051133054 cites W1993750136 @default.
• W2051133054 cites W1993965498 @default.
• W2051133054 cites W2001088431 @default.
• W2051133054 cites W2004558472 @default.
• W2051133054 cites W2010074472 @default.
• W2051133054 cites W2011044541 @default.
• W2051133054 cites W2012547110 @default.
• W2051133054 cites W2016451055 @default.
• W2051133054 cites W2017026587 @default.
• W2051133054 cites W2017253439 @default.
• W2051133054 cites W2019196831 @default.
• W2051133054 cites W2019900217 @default.
• W2051133054 cites W2023876571 @default.
• W2051133054 cites W2029446823 @default.
• W2051133054 cites W2034562207 @default.
• W2051133054 cites W2037803861 @default.
• W2051133054 cites W2039042948 @default.
• W2051133054 cites W2040170012 @default.
• W2051133054 cites W2048698611 @default.
• W2051133054 cites W2051237723 @default.
• W2051133054 cites W2063042268 @default.
• W2051133054 cites W2063647809 @default.
• W2051133054 cites W2066719325 @default.
• W2051133054 cites W2068703170 @default.
• W2051133054 cites W2074079341 @default.
• W2051133054 cites W2079768124 @default.
• W2051133054 cites W2091330133 @default.
• W2051133054 cites W2120658132 @default.
• W2051133054 cites W2120714534 @default.
• W2051133054 cites W2124754604 @default.
• W2051133054 cites W2145107163 @default.
• W2051133054 cites W2147465991 @default.
• W2051133054 cites W2149949545 @default.
• W2051133054 cites W2153858533 @default.
• W2051133054 cites W4243110249 @default.
• W2051133054 doi "https://doi.org/10.1016/j.neuroscience.2009.07.025" @default.
• W2051133054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2773563" @default.
• W2051133054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19619615" @default.
• W2051133054 hasPublicationYear "2009" @default.
• W2051133054 type Work @default.
• W2051133054 sameAs 2051133054 @default.
• W2051133054 citedByCount "15" @default.
• W2051133054 countsByYear W20511330542012 @default.
• W2051133054 countsByYear W20511330542013 @default.
• W2051133054 countsByYear W20511330542015 @default.
• W2051133054 countsByYear W20511330542016 @default.
• W2051133054 crossrefType "journal-article" @default.
• W2051133054 hasAuthorship W2051133054A5012733271 @default.
• W2051133054 hasAuthorship W2051133054A5021222735 @default.
• W2051133054 hasAuthorship W2051133054A5038633022 @default.
• W2051133054 hasAuthorship W2051133054A5052509069 @default.
• W2051133054 hasAuthorship W2051133054A5076025191 @default.
• W2051133054 hasBestOaLocation W20511330542 @default.
• W2051133054 hasConcept C118552586 @default.
• W2051133054 hasConcept C126322002 @default.
• W2051133054 hasConcept C134018914 @default.
• W2051133054 hasConcept C148762608 @default.
• W2051133054 hasConcept C15744967 @default.
• W2051133054 hasConcept C170493617 @default.
• W2051133054 hasConcept C173586616 @default.
• W2051133054 hasConcept C2781012912 @default.
• W2051133054 hasConcept C44752575 @default.
• W2051133054 hasConcept C558461103 @default.
• W2051133054 hasConcept C61174792 @default.
• W2051133054 hasConcept C67018056 @default.
• W2051133054 hasConcept C71924100 @default.
• W2051133054 hasConcept C86803240 @default.
• W2051133054 hasConcept C98274493 @default.
• W2051133054 hasConceptScore W2051133054C118552586 @default.
• W2051133054 hasConceptScore W2051133054C126322002 @default.
• W2051133054 hasConceptScore W2051133054C134018914 @default.
• W2051133054 hasConceptScore W2051133054C148762608 @default.
• W2051133054 hasConceptScore W2051133054C15744967 @default.

• next